Literature DB >> 13271567

A disorder of blood coagulation in systemic lupus erythematosus.

S L LEE, M SANDERS.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION; LUPUS ERYTHEMATOSUS/blood in

Mesh：

Year:  1955        PMID： 13271567      PMCID： PMC438765          DOI： 10.1172/JCI103237

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  17 in total

1.  The thromboplastin generation test.

Authors:  R BIGGS; A S DOUGLAS
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

2.  A simple method of studying the generation of thrombin in recalcified plasma; application in the investigation of haemophilia.

Authors:  W R PITNEY; J V DACIE
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

3.  A specific inhibitor for human desoxyribonuclease and an inhibitor of the lupus erythematosus cell phenomenon from leucocytes.

Authors:  N B KURNICK; L I SCHWARTZ; S PARISER; S L LEE
Journal:  J Clin Invest       Date:  1953-03       Impact factor: 14.808

4.  Quantitative test for antibody-globulin coating human blood cells and its practical applications.

Authors:  A S WIENER; E B GORDON
Journal:  Am J Clin Pathol       Date:  1953-05       Impact factor: 2.493

5.  The demonstration of the L.E. phenomenon in patients with penicillin hypersensitivity.

Authors:  J R WALSH; H J ZIMMERMAN
Journal:  Blood       Date:  1953-01       Impact factor: 22.113

6.  Disorders of the blood in disseminated lupus erythematosus.

Authors:  C L CONLEY
Journal:  Am J Med       Date:  1952-07       Impact factor: 4.965

7.  Acquired hemolytic anemias the presenting syndrome of lupus erythematosus disseminatus.

Authors:  E L DUBOIS
Journal:  Am J Med       Date:  1952-02       Impact factor: 4.965

8.  A simple test for L. E. cells.

Authors:  S L LEE
Journal:  Am J Clin Pathol       Date:  1951-05       Impact factor: 2.493

9.  The L.E. (lupus erythematosus) cell; clinical and chemical studies.

Authors:  S L LEE; S R MICHAEL; I L VURAL
Journal:  Am J Med       Date:  1951-04       Impact factor: 4.965

10.  The one-stage prothrombin consumption test; clinical value in the identification of thromboplastin-deficiency diseases.

Authors:  M STEFANINI; W H CROSBY
Journal:  Blood       Date:  1950-10       Impact factor: 22.113
View more
  8 in total

Review 1.  Antiphospholipid syndrome: multiple mechanisms.

Authors:  C G Mackworth-Young
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 2.  Antiphospholipid syndrome: laboratory testing and diagnostic strategies.

Authors:  Thomas L Ortel
Journal:  Am J Hematol       Date:  2012-03-31       Impact factor: 10.047

Review 3.  Influence of the lupus anticoagulant on clotting tests.

Authors:  J Vermylen; J Arnout
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 4.  Laboratory diagnosis of the lupus anticoagulant.

Authors:  Thomas L Ortel
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 5.  Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances.

Authors:  Arne Vandevelde; Katrien M J Devreese
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

6.  A circulating anticoagulant occurring after temporal arteritis and controlled by corticosteroid therapy.

Authors:  A G WHITFIELD; M J MEYNELL; B M FESSEY; W A HUDSON
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

Review 7.  Antiphospholipid syndrome: an overview.

Authors:  John G Hanly
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

8.  Correction by defects in clotting accelerator activity by administration of methionine and vitamin K and of a new sulfhydryl-substituted methylnaphthoquinone, vitamin K-S(II).

Authors:  J R CARTER; E D WARNER
Journal:  J Clin Invest       Date:  1958-01       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.